Beacon Investment Advisory Services Inc. Sells 300 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Beacon Investment Advisory Services Inc. lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 11.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,350 shares of the financial services provider’s stock after selling 300 shares during the quarter. Beacon Investment Advisory Services Inc.’s holdings in iShares Biotechnology ETF were worth $342,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $29,000. Highline Wealth Partners LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth $30,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF during the 2nd quarter worth $31,000. Ashton Thomas Securities LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth $36,000. Finally, Voisard Asset Management Group Inc. purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth $59,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.1 %

IBB opened at $141.73 on Tuesday. The firm’s fifty day moving average price is $142.71 and its two-hundred day moving average price is $142.09. iShares Biotechnology ETF has a 1 year low of $121.84 and a 1 year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.